commit b980fb39cfb5f5fb7f1f6bb35f88311ef8f92f64
Author: dulcieparkhurs <dulcie-parkhurst.3326@topcompanygroup.com>
Date:   Thu Apr 2 16:26:31 2026 +0000

    Add Testosterone and Prostate Cancer: A Guide to the New Science

diff --git a/Testosterone-and-Prostate-Cancer%3A-A-Guide-to-the-New-Science.md b/Testosterone-and-Prostate-Cancer%3A-A-Guide-to-the-New-Science.md
new file mode 100644
index 0000000..9f16260
--- /dev/null
+++ b/Testosterone-and-Prostate-Cancer%3A-A-Guide-to-the-New-Science.md
@@ -0,0 +1,7 @@
+<br>
+<br>If a man's testosterone is below the normal range, it's best to repeat it once more to be sure before starting testosterone therapy - often staying on it indefinitely. Just being tired isn't enough to seek [testosterone online pharmacy](http://gbtk.com/bbs/board.php?bo_table=main4_4&wr_id=353079) replacement therapy. Your cancer team can best advise you if you may benefit from hormonal therapy.. Prevalence estimates of LOH vary widely depending on study methods, populations and diagnostic criteria used. In a large, multi-institutional study of 3369 men aged 40 to 79 years, the European Male Aging Study (EMAS) attempted to better define the symptom complex of LOH. The decline in total testosterone is further influenced by an increase in SHBG that occurs with aging, which may lower bioavailable testosterone Vermeulen and Kaufman, 1995; Muller et al. 2003. The resulting amplitude of peak morning testosterone is decreased in older men, making morning testosterone measurement a useful laboratory marker in the diagnosis of LOH Bremner et al. 1983; Tenover et al. 1988; Wang et al. 2008. For instance, Ellison and colleagues demonstrated young adult elevations in testosterone and subsequent age-related declines in US and Congo populations, but not in Nepal or Paraguay Ellison et al. 2002. DHT also plays a well-established role in promoting continued growth of the adult prostate, leading to benign prostatic hypertrophy (BPH) Huggins, 1947; Andriole et al. 2004.|Those in the TRT group did see their PSA levels rise during the first year of using the gel. For men who genuinely have low testosterone, this change is important. A large part of these discussions is about prostate safety and reflects how far the evidence has shifted. They become super-sensitive to any testosterone signals they can detect. In the early 1990s, Harvard urologist and [buy testosterone cream online](http://dsmcase.com:2180/leonoraston46/leonor2002/wiki/Evaluating-testosterone-raising-supplements-for-men-age-60-and-older) pioneer Abraham Morgentaler began to challenge this view. Its job is to produce the fluid that helps transport sperm, and it relies heavily on testosterone to do so.|The testosterone users also reported few symptoms of an enlarged prostate, such as frequent urination, difficulty urinating, and dripping. For 14 months, the men used either a topical testosterone gel at a dose designed to maintain normal testosterone levels, or an inactive (placebo) gel. The idea is to use testosterone itself as a weapon to confuse and kill cancer cells that have learned to survive without it. The answer lies in how prostate cells react to different amounts of testosterone.|For some men, symptoms of prostate cancer can include frequent urination, painful ejaculation,  [git.gotrobotics.org](https://git.gotrobotics.org/callum35n05875) erectile dysfunction, or blood in the urine. "I hope this campaign inspires others to appreciate the small, meaningful moments in life and take proactive steps when it comes to prostate cancer screening and treatment management. "Partnering with Bayer has allowed me to engage in some of the most meaningful work of my career—spotlighting the everyday experiences of patients with advanced prostate cancer," Tony says.|Rarely, prostate cancer forms from other types of cells. Also testosterone is known to stimulate growth of prostate cancer in men diagnosed with the condition. Older observational studies suggested that long term [buy testosterone propionate](http://175.27.229.211:3000/arielleenderby/www.beyoncetube.com5070/wiki/How-to-do-the-barbell-bicep-curl-to-build-bigger-biceps) use could increase their risk of cardiovascular disease. Millions of American men use a prescription testosterone injection or gel as forms of testosterone replacement therapy (often referred to as TRT therapy) to restore normal levels of the manly hormone. Hormone therapy is used to treat stage 2–4 prostate cancer. Many cancers become resistant to hormone therapy over time.|Doctors also watch out for high red blood cell counts, which could increase the risk of clotting. Men get started on testosterone replacement and they feel better, but then it's hard to come off of it. General fatigue and malaise has so many other causes, and when most men get a blood test, the result is a normal testosterone level. Marketers urge men to talk to their doctors if they have certain "possible signs" that mean they could need low-T treatment. The ongoing pharmaceutical marketing blitz promises that low-T treatment can make men feel more alert, energetic, mentally sharp, and sexually functional. Your doctor can help you develop ways to reduce these symptoms.|So how can this paradox exist with evidence that normal [buy testosterone online no prescription](http://all.caeta.mx:3000/mildredcupp757) levels are not harmful? Recent medical studies now show that [buy testosterone cypionate](http://git.chilidoginteractive.com:3000/royalcarney607) treatment is safe. This led to the proposal of the "saturation model", which suggests that prostate tissue is sensitive to testosterone only at very low levels. "We have already developed new drugs that exploit this new mechanism and are bringing these to the clinic for evaluation as prostate cancer therapeutics."|After a median follow up of 2.5 years, two men had upgrading on subsequent biopsy, but no cases of disease or PSA progression were seen Morgentaler et al. 2011. Studies on TRT in patients with PrCa enrolled in active surveillance (AS) programs provide valuable information on possible tumor progression in PrCa patients, given the frequency of exams, biopsies and close follow up in this population. Leibowitz and colleagues reported on 96 men with PrCa who began high-dose TRT after undergoing primary PrCa treatment. There was an overall increase in serum PSA, but no evidence of increased cancer recurrence over 36 months Pastuszak et al. 2013.}
+The development of hormonal therapies led to a drastic decline in prostate cancer deaths in the mid-1990s. Prostate cancer requires male sex hormones called androgens to grow. For many men, living a full life with good energy and drive is possible, even with a history of prostate cancer. So, what does this mean for you, especially if you’ve already been treated for prostate cancer? Once the cancer cells have absorbed a small amount of testosterone, giving them more doesn’t really speed up their growth. Prostate cancer cells seem to work in a similar way with [purchase testosterone](http://TeArs.pt/@sabine68o6820?page=about). Doctors found that if a man had prostate cancer that had spread, removing his testicles dramatically slowed the cancer down.
+Using Surveillance, Epidemiology, and End Results (SEER)-Medicare data, Kaplan and colleagues reported on 149,354 men including 1181 men who received TRT after a diagnosis with PrCa. In 1982, Fowler and Whitemore reported on 52 men with metastatic PrCa patients with bone metastasis, with 65% having had a prior orchiectomy. By one estimate, 6000 patients receiving 5 years of TRT would be needed to detect a 30% increase in PrCa incidence Bhasin et al. 2003. With a median follow up of 5 years, the incidence of PrCa was lower in TRT-treated populations than accepted incidence rates from large population-based studies with long-term follow up Andriole et al. 2009; Schroder et al. 2012; Haider et al. 2014. Haider and colleagues reported on three prospective cohort studies comprising a total of 1023 hypogonadal men with PSA Haider et al. 2014.|If you have prostate cancer, testosterone is like pouring gasoline on a fire. By the end of that period, the number of men diagnosed with prostate cancer was equally low in both the testosterone and placebo groups. Higher levels of testosterone may push these cancer cells into a more stable, slower growth state and, in some situations, may even destabilise them, promoting cell death. New long-term research even suggests that men whose testosterone levels are properly restored and monitored by doctors may actually have lower cancer rates. For more than 80 years, men have been told that testosterone helps prostate cancer grow.|[buy testosterone propionate](https://fanajobs.com/profile/alycewindradyn) is a sex hormone, also known as an androgen. Thus, until the results of future RCTs are available, TRT should only be offered to select patients who are carefully monitored and well-informed about the potential risks and benefits. With concerns that testosterone can stimulate cancer growth, TRT in men with PrCa remains controversial. Whether hypogonadism promotes high-risk disease or is rather a symptom of high-risk disease remains unknown. However, after a large number of mostly retrospective studies, there remains no clear association with higher endogenous testosterone and the development or severity of PrCa. There is good evidence that androgens can promote PrCa in animal models and that ADT is beneficial in PrCa patients. There is an apparent disconnect between data supporting androgen-driven PrCa growth and the clinical data, although limited, demonstrating no increase in PrCa growth or progression in men on TRT.|Androgen levels above the saturation point will have no further stimulatory effect, thus raising serum testosterone concentrations above the saturation point, as often seen with TRT, fails to induce growth of prostate tissues. The androgen hypothesis and robust clinical data supporting ADT in advanced PrCa have helped foster the dogma that TRT in PrCa patients is ‘like feeding the fire’. In a systematic review of 40 prospective studies of TRT in men without PrCa, no study demonstrated an association between TRT and PrCa risk. In a study of 673 men undergoing prostatectomy, Salonia and colleagues examined the association of morning testosterone with surgical pathology outcomes. Several studies have implicated lower testosterone with higher Gleason grade at the time of prostatectomy. They measured morning testosterone levels and compared 103 men diagnosed with BPH with 103 men diagnosed with PrCa.|There are a number of studies examining testosterone levels prior to prostate biopsy in men with suspected PrCa. A prospective cohort study of Korean men undergoing prostate biopsy for suspected PrCa compared biopsy results among men with low [buy testosterone booster](https://khmerhd.tv/@shanice61d2173?page=about), defined as total testosterone levels below the median of 13.3 nmol/l (385 ng/dl). It should be noted that longitudinal studies of this kind are limited in that serum testosterone levels were not routinely drawn in the morning, and thus may not reflect the true peak circulating androgen levels.|The fear linking [testosterone buy online](https://hikvisiondb.webcam/wiki/User:Anh64399607064) to prostate cancer didn’t come out of nowhere. Let’s clear up the confusion surrounding testosterone and prostate cancer so you can make decisions that feel right for you. The connection between [buy testosterone cream](https://git.suo0.com/jamessteed9690) and prostate cancer is far more complex than that simple, terrifying idea.}
+The Gleason score allows your provider to rate how abnormal your cancer cells are. Doctors use screening tests, physical exams, scans and, sometimes, a biopsy to diagnose prostate cancer. Luckily, prostate cancer usually grows slowly. Experts aren’t sure what causes cells in your prostate to become cancer cells. But as prostate cancer progresses, you may start to notice changes. If you’re diagnosed with prostate cancer, it’s most likely an adenocarcinoma. Still, approximately 35,770 people in the United States die from prostate cancer each year.
+Just like so many families dealing with the disease—in the U.S. more than 300,000 new cases are expected to be diagnosed in the next year—the Romos know there can be uncertainty. "When you find out you have cancer, it’s a lot to process," he says. He wanted to know if his dad’s cancer was rare or common, and what the numbers said.
+<br>
\ No newline at end of file